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In  higher animals, 1,1,3-tricyano-2-aminopropene (TCAP) has a 
var ie ty  of e f f e c t s  on cen t r a l  nervous t i s sue .  Grenell (1) reported 
t h a t  it caused a spec i f ic  increase i n  the content of  u l t r av io l e t  ab- 
sorbing mater ia l  (presumably nucleic ac ids)  i n  rabbi t  sp ina l  ganglion, 
cord an te r io r  horn, cerebe l la r  Purkinje and c o r t i c a l  pyramidal c e l l s  
of t he  rabbi t .  When administered a t  20 mg/kg body weight, it caused 
an increase i n  the  RNA and protein content of Dei te r ' s  nerve c e l l s  
while reducing t h e i r  content i n  associated g l i a ,  and also accentuated 
differences i n  composition of the RNA of the two c e l l  types ( 2 ) .  
w a s  shown recent ly  t h a t  when 1 5  pg/gm of TCAP w a s  given t o  rats, 
there  was an enhanced re ten t ion  o f  learning i n  an avoidance condi- 
t ioning s i tua t ion  (3 ) .  
t h a t  TCAP grea t ly  s t i m u l a t e d  the i n  v i t r o  incorporation of ur idine 
i n t o  the  nucleolar RNA of dipteran sal ivary glands. Further,  it re- 
versed the  inh ib i t ion  of uridine incorporation i n t o  nucleolar RNA by 
actinomycin D, which suggests t h a t  TCAP stimulated DNA-dependent RNA 
It 
Most recently,  Jacob and S i r l i n  reported ( 4 )  
synthesis.  
We were interested i n  determining whether TCAP would produce 
changes i n  f rog nervous t i s s u e  nucleic acids  similar t o  those ob- 
served i n  higher ver tebrates .  If TCAP a f f e c t s  s t ruc tures  of t he  
nervous system associated with learning, it might be expected t o  
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have a l e s s e r  e f f e c t  on lower animals. 
an -- i n  v i t r o  system which would maintain these  t i s s u e s  i n  a viable 
Our approach was t o  devise 
condition f o r  a suf f ic ien t  period t o  permit t he  determination of 
t h e i r  a b i l i t y  t o  incorporate various radioact ive precursors of the  
nucleic acids  and proteins .  
Materials and Methods. The frogs, a catesbeiana (American 
bull f rog) ,  weighing approximately 350 gm, were obtained from the  
D a h 1  Company, Berkeley, California and used immediately o r  kept i n  
storage a t  10 C.  f o r  a short  time. After anesthesia with e ther ,  
0 
the  brain was removed under s t e r i l e  conditions.  
t he  olfactory bulbs, w a s  washed with cold medium, and cut i n t o  three 
major portions:  t he  medulla, opt ic  t r a c t  and bulb, and cerebral  hemi- 
spheres. These were i n  tu rn  separately cut i n t o  pieces approximately 
The t i s sue ,  minus 
1 mmJ, which were then placed i n  stoppered 11 x 75 mm g lass  tubes i n  
such a manner t h a t  each tube had the same d i s t r ibu t ion  of mater ia l .  
Ganglia were obtained by s t e r i l e  dissect ion,  re jec t ing  t h e  l a rge  
second ganglion, and incubated individually.  
The medium, a modification of one described by Wolf (5)  f o r  
maintaining dissociated e catesbeiana kidney and hear t  c e l l s ,  
contained 10% Hank's Balanced Sal t  Solution,* 45% Ear le ' s  Balanced 
S a l t  Solution, 30% Medium 199, 10% fe ta l  bovine serum, 400 units/ml 
each of p e n i c i l l i n  and streptomycin, and w a s  adjusted t o  pH 7.35 
w i t h  7.5% NaHC03. With tri-weekly changes of f lu id  and a i r  as t h e  
~ 
* All t i s s u e  cul ture  components were obtained as prepared solut ions 
from Microbiological Associates, Albany, California.  
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gas phase, frog b ra in  t i s s u e  could be maintained f o r  up t o  three  weeks. 
However, t h e  t i s s u e  was used immediately i n  t h e  experiments t o  be re- 
ported here and the  incubation time w a s  18 hours a t  16-18' C. 
were incubated i n  90$ Medium 199, 10% f e t a l  c a l f  serum, and 0 .2s  
glucose with an t ib io t i c s ,  pH, and conditions as before.  
Ganglia 
The isotopic  precursors used were obtained from the  New England 
Nuclear Corporation and had the  indicated spec i f i c  a c t i v i t i e s  : H3-uri- 
dine (15.3 mc/mg), H3-cytidine (25 mc/mg), H3-thymidine (31 mc/mg), 
ade11ine-2-C~~ (0.059 mc/mg ) , guanine-2-C14 (0.022 mc/mg ) , and val ine- l -  
C l 4  (0.053 mc/mg). 
Incubations were terminated by washing the t i s sue  twice with cold 
phosphate-buffered sal ine,  and then separating t h e  mater ia l  i n t o  a 
low molecular weight (LMW), RNA, DNA, and protein f r ac t ions  by a modi- 
f i ca t ion  of t he  Schmidt-Thanhauser method (6) .  
LMW, RNA, and DNA f rac t ions  was determined using a Beckman Model DB 
spectrophotometer. A Packard l iquid s c i n t i l l a t i o n  counter was used t o  
The absorbancy of the  
determine the  content of rad ioac t iv i ty  of an al iquot  of the  individual 
f rac t ions  dispersed i n  a toluene counting solut ion containing .35$ 
terphenyl, .O25$ POPOP, 4$ hyamine, and 1% formic acid.  
Results. I n i t i a l  experiments were conducted t o  determine whether 
the  t i s s u e s  were able  t o  incorporate s ign i f icant  amounts of radioac- 
t i v i t y  during an 18-hour incubation. Easi ly  determinable amounts of 
a l l  t he  precursors except H'-thymidine were incorporated. 
mately 0.4$ of t h e  added radioact ivi ty  was found i n  the LMW f rac t ion  
and 0.2s i n  the  RNA f rac t ion .  
H -thymidine was expected since t h e  t issues were not engaged i n  for-  
Approxi- 
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mation of new DNA. It was fur ther  observed t h a t  only a negl ig ib le  
amount of rad ioac t iv i ty  from t h e  other  precursors w a s  incorporated 
i n t o  the DNA. 
single  i so topic  precursor i n  the  medium. 
with paired H3- and Cl4-precursors were i n i t i a t e d .  Comparison of 
r e s u l t s  with e a r l i e r  experiments showed t h i s  t o  be a qu i t e  satis- 
These ea r ly  experiments were conducted with only a 
Dual labe l ing  experiments 
factory procedure. 
A study w a s  performed t o  determine t h e  e f f e c t  of increasing 
amounts of TCAP on the  incorporation of H3-uridine i n t o  the  RNA 
f rac t ion  and C14-valine i n t o  the protein f r ac t ion  of cen t r a l  nervous 
t i s sue .  It can be seen from Table I t h a t  there  i s  a progressively 
grea te r  inh ib i t ion  of incorporation with no indicat ion of stimula- 
t i o n  a t  5 pg/ml. 
s t r a igh t  l i n e s  with d i f f e r ing  slopes are obtained f o r  t he  d i f f e r e n t  
precursors. 
When the  d a t a  i s  p lo t ted  on "probit" paper, 
The grea te r  slope with H3-uridine suggests a more d i r e c t  
e f f ec t  on newly synthesized nucleic acids  than on proteins .  The re- 
s idual  incorporation of rad ioac t iv i ty  i n t o  t i s s u e s  poisoned with a 
high concentration of azide may be due t o  e i t h e r  non-specific ad- 
sorption o r  t o  metabolic a c t i v i t i e s  using energy s to re s  present i n  
the  c e l l s  p r i o r  t o  inh ib i t ion  of resp i ra t ion  by the  azide.  
The r e s u l t s  of a representative experiment performed t o  compare 
the  e f f e c t s  of TCAP with those of DNP and azide a r e  shown i n  Table 11. 
The concentrations of TCAP, DNP, and azide selected were those which 
have been shown (7, 8)  t o  i nh ib i t  by 50% the  oxidative phosphoryla- 
t i o n  of mitochondria. The incorporation of precursors i n t o  the  DNA 
and protein f rac t ions  was negl igible  and i s  not shown. In  general ,  
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t h e  compounds were somewhat inhibi tory.  
20 pg/ml of TCAP inhibi ted C14-valine incorporation i n t o  the  protein 
f rac t ion  by 40$. The apparently grea te r  incorporation of H3-uridine 
i n t o  the  LElw f rac t ion  i n  t he  presence of TCAP i n  t h i s  experiment w a s  
not a reproducible r e su l t ,  nor was t h e  apparent grea te r  inh ib i t ion  of 
H3-cytidine incorporation. I n  general, the  var iab le  nature of t he  
experimental material precluded exact rep l ica t ion  of r e s u l t s  as i s  
In a separate experiment, 
evident from the  la rge  standard e r ro r s  shown i n  the  t a b l e  f o r  some 
conditions. 
Discussion. The biochemical processes involved whereby TCAP 
can produce an a l t e r a t i o n  inthe RNA base composition of nervous tis- 
sue a r e  not understood. A var ie ty  of metabolic e f f e c t s  of TCAP have 
been described, but it i s  probable t h a t  most of these are of secon- 
dary nature.  Thus, the  observation t h a t  it i n h i b i t s  organic binding 
of iodine by the  thyroid, suppresses the  formation of thyroxine, and 
i n h i b i t s  t he  conversion of monoiodotyrosine t o  diiodotyrosine ( 9 )  i s  
d i f f i c u l t  t o  r e l a t e  t o  nucleic  acid metabolism. 
In  the  experiments reported here, t he  radioact ive precursors 
must first be phosphorylated before they can be incorporated i n t o  
RNA. 
a c t iv i ty .  There is some evidence t h a t  TCAP has an e f f e c t  on oxida- 
t i v e  phosphorylation and the  formation of ATP, s ince Eberts (7) 
demonstrated t h a t  it uncoupled phosphorylation associated with oxi- 
dat ion of various t r icarboxyl ic  ac id  cycle intermediates i n  a manner 
similar t o  2,4-DNP. 
Incorporation i n t o  the  LMW pool only p a r t i a l l y  r e f l e c t s  t h i s  
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The r e s u l t s  were not  t h e  same i n  t h e  two tissues investigated.  
TCAP inhibi ted the  i n  v i t r o  incorporation of val ine and ur id ine  i n t o  
frog cent ra l  nervous t issue,  but only val ine incorporation w a s  in- 
h ib i ted  i n  ganglia. 
of two inh ib i to r s  of oxidative phosphorylation using ganglia,  no 
major e f f e c t  was observed. 
vation of Ekerts (10) t h a t  TCAP had no ef fec t  on the  incorporation 
of U-$4-glucose o r  CI4-lysine in to  protein,  RNA, o r  DNA of the  cere- 
brum, cerebellum, midbrain, cord, o r  whole bra in  of  rabbi t s .  
When the  effect  of TCAP w a s  compared with t h a t  
These da t a  may be compared t o  t h e  obser- 
It i s  possible  t h a t  some other metabolic a c t i v i t y  of TCAP i s  
more closely re la ted  t o  i t s  i n  vivo e f f e c t  on nucleic acid metabolism. 
It has a d i r e c t  e f f ec t  on resp i ra t ion  since it increased oxidation of 
ace ta te ,  t r ipa lmi t in ,  leucine,  and glycine i n  rats with increased C+ 
output (11). Again, TCAP a t  low concentrations appreciably inhibi ted 
the  reduction of crotonyl-CoA by rat l iver  microsomes (12). Most 
analogous t o  the  r e s u l t s  obtained here i s  the  observation by Mendelson 
and Warmouth (13) t h a t  TCAP, i n  rat brain cortex s l i ce s ,  produced a 
marked s t h u l a t i o n  of 02 uptake, whereas s l i c e s  removed from rats ad- 
ministered TCAP i n  vivo respired a t  t h e  same rate as controls .  In -- 
contrast ,  2,4-DNP, which uncoupled oxidative phosphorylation, did not 
stimulate 02 uptake. 
Summary. The e f f e c t s  of TCAP on t h e  incorporation of C14-adenine, 
C1'-guanine, H3-uridine, H3-cytidine, and C14-valine i n t o  frog cen t r a l  
and peripheral  nervous tissue maintained i n  v i t r o  was  observed. TCAP 
inhibi ted C1'-valine incorporation i n t o  the  protein f r ac t ion  of both 
t i s sues .  However, H3-uridine incorporation i n t o  RNA w a s  inhibi ted 
-6 - 
only in brain t i s s u e ,  TCAF' caused changes i n  the  nucleic acid metabo- 
l i s m  of f rog ganglia qu i te  similar t o  those produced by DNP and azide.  
\ 
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TABLE I. Effect of Varying Concentrations of TCAP on the  i n  v i t r o  Incor- 
poration of H 3 -Uridine and C14-Valine by Frog Central  Nervous Tissue* 
Incorporation 
14 Addenda Ur id ine -E3 Valine-C 
(2!LC/ml) (0.5pc/ml) 
None 7,300 2 600 160 - + 60 
5 I . @ / &  TCm 6,600 - + 600 150 2 40 
20 vg/ml TCAP 2,900 2 200 50 2 5 
50 TCAP 1,900 - + 200 35 2 5 
100 pg/ml TCAP 
2 m g / d  azide - 
1,100 - + 100 40 - + 5 
20 + 5 170 2 90 - 
~- ~~ ~ 
i * Data i s  summarized from two d i f fe ren t  experiments. Incorporation is  mean 
t o t a l  cpm - + S.E. f o r  t h ree  rep l ica te  tubes each containing 0.5 m l  of medium 
and 10 mg of t i s sue .  
. .  
TABU 11. Effect of Oxidative Phosphorylation Inh ib i to r s  on t h e  i n  v i t r o  Nucleic 
Acid Metabolism of Frog Ganglia 
Low Molecular 
Weight Fraction 
None 5,600 2 390 12,210 - + 860 8,500 2 2,690 5,060 2 1,460 
75 W / d  TCAP 7,140 2 1,990 13,570 2 2,260 4,530 2 630 3,770 2 620 
2 v g / d  D W  3,680 2 460 10,020 - + 1,930 6;;500 - + 2,550 2,920 - + 890 
I 1 5  p g / d  azide 5,660 + 220 13,550 2 1,090 5,470 2 470 3,600 2 1,490 - 
RNA Fraction 
None 1,200 2 280 1,260 - + 130 1,970 - + 730 300 2 30 
75 P g / d  TCA.P 1,300 2 370 . 1,110 - + igo 1,030 - + 50 220 + 70 
I 
2 DNP 840 2 60 1,160 - + 220 1,070 2 70 260 2 90 
I 
1,180 + 40 1,810 + 500 470 2 180 1 5  p g / d  a z i d e  560 - + 150 - - 
* Values given a re  t h e  mean 5 S.E. f o r  three r ep l i ca t e  incubations.  
(0.5 m l )  contained e i t h e r  1 pc  each of ~ r id ine -H3/aden ine -C~~  o r cytidine-H3/ 
The medium 
guanine- $4. 
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